Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus mice
- 8 January 2021
- journal article
- research article
- Published by Elsevier BV in Immunology Letters
- Vol. 231, 49-60
- https://doi.org/10.1016/j.imlet.2020.12.012
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 76 references indexed in Scilit:
- Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III StudyArthritis & Rheumatism, 2013
- Examination of Thymic Positive and Negative Selection by Flow CytometryJournal of Visualized Experiments, 2012
- Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trialAnnals Of The Rheumatic Diseases, 2011
- Molecular resolution of the B cell landscapeCurrent Opinion in Immunology, 2011
- Improving RNA-Seq expression estimates by correcting for fragment biasGenome Biology, 2011
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbonsTrends in Immunology, 2009
- IRF8 regulates B-cell lineage specification, commitment, and differentiationBlood, 2008
- KEGG for linking genomes to life and the environmentNucleic Acids Research, 2007
- The Thymus Is a Common Target Organ in Infectious DiseasesPLoS Pathogens, 2006
- Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosusAutoimmunity Reviews, 2004